Researchers create stable chiral molecules with novel stereogenic centers for future medicines

Jul, Tue, 2025
Innova1
Purchase & Order

Chirality: like a right hand and a left hand, two molecules can have the same composition, but a different shape and arrangement in space. And this difference can change everything. Understanding and controlling this phenomenon is crucial to drug design.

Gold-catalyzed chemical reaction advances next-generation anticancer prodrugs
Anticancer prodrugs have attracted significant attention from the medical and scientific communities in recent years because of their potential to improve treatment precision while reducing side effects. These drugs are engineered to remain inactive until they are activated at specific sites or under particular physiological conditions within the body, at which point they release their therapeutic effect.
Spent coffee grounds reveal a route to biodiesel and other bio-based products
Coffee grounds that usually end up being thrown away can have a second life as a raw material for producing biofuels and other high-value-added products. A study by the Universitat Rovira i Virgili (URV) has evaluated how to extract oil from coffee grounds efficiently while preserving the rest of the plant material so that it can also be used in other processes.
Melts in your mouth, but not in your car: The ongoing scientific quest to create heat‑resistant chocolate
There are few pleasures greater than letting a piece of chocolate melt slowly on your tongue. Indeed, the proximity of chocolate's melting point to our own body temperature is one reason it is so widely appreciated.
Open-source AI predicts key peptide traits before costly lab testing
Penn Engineers have developed PeptiVerse, an AI-powered platform that predicts key chemical and biological properties of peptides, strings of amino acids whose medical potential has been demonstrated by the success of GLP-1 drugs, widely used weight-loss treatments.
Novel antibiotic candidates starve resistant bacteria by blocking vitamin supply
Bacteria have spent decades evolving resistance to virtually every antibiotic we have thrown at them. To stay ahead, new drugs must hit targets that existing antibiotics have never touched. A research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a series of synthetic drug candidates that do exactly that: By blocking an essential molecular supply system, these molecules cut off the bacteria's supply of essential vitamins and starve them to death. The team published its findings in two studies in the Journal of Medicinal Chemistry.